Berkley Stephens
Women's Health · Dallas, TXNPI 1629671961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $612 and has fallen 75.5% since, to $150 in 2025.
Across 89 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$360
- Astellas Pharma US Inc$236
- Mayne Pharma Commercial LLC$149
- Pfizer$135
- Shield Therapeutics Inc$119
- Sumitomo Pharma America, Inc.$117
- plus $683 from 17 others
What the payments were for
- Food & beverage$1,64892%
- Education$1518%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $360 |
| Astellas Pharma US Inc | 7 | $236 |
| Mayne Pharma Commercial LLC | 7 | $149 |
| Pfizer | 6 | $135 |
| Shield Therapeutics Inc | 5 | $119 |
| Sumitomo Pharma America, Inc. | 6 | $117 |
| Ascend Therapeutics US, LLC | 1 | $103 |
| Organon | 6 | $90 |
| Aspira Women's Health Inc | 4 | $64 |
| Radius Health, Inc. | 2 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Biogen | 2 | $38 |
| Bayer | 2 | $38 |
| Myovant Sciences Inc. | 2 | $36 |
| Scynexis, Inc. | 2 | $35 |
| Avion Pharmaceuticals | 2 | $34 |
| Exeltis, USA Inc. | 2 | $31 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Agile Therapeutics, Inc. | 2 | $26 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESTROGEL$103
How this compares
$1,799 in reported general payments places this provider in the 85th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Blisovi FeNorethindrone-E.Estradiol-Iron | 12 | $304 |
Paid to pharmacies, not to this prescriber.
Other women's health in Dallas
- Christina HicksDallas$8K
- Sarah GoughDallas$5K
- Barbara MaukDallas$4K
- Brianna AcostaDallas$3K
- Annette BaconDallas$3K
- Kris HumphreyDallas$3K
- Vicki DonoskyDallas$3K
- Carolyn MilliganDallas$2K
- Mahnaz MostofiDallas$2K
- Evelyn TingGrapevine$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.